BCL2 and neuroblastoma: One target of miR-16 is Bcl-2 (Yan et al., 2013); miR-186 from peripheral blood NK-derived exosomes has been shown to inhibit proliferation of neuroblastoma cells by targeting TGFβ1 and other proliferation genes (Neviani et al., 2019).